Altered expression of glycobiology-related genes in Parkinson’s disease brain
The precise mechanisms initiating and perpetuating the cellular degeneration in Parkinson’s disease (PD) remain unclear. There is decreased expression of the main brain gangliosides, and GM1 ganglioside in particular, in the PD brain along with decreased expression of the genes coding for the glycos...
Main Authors: | Jay S. Schneider, Garima Singh |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2022-11-01
|
Series: | Frontiers in Molecular Neuroscience |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fnmol.2022.1078854/full |
Similar Items
-
Explorative Combined Lipid and Transcriptomic Profiling of Substantia Nigra and Putamen in Parkinson’s Disease
by: Helena Xicoy, et al.
Published: (2020-08-01) -
Naringin ameliorates motor dysfunction and exerts neuroprotective role against vanadium-induced neurotoxicity
by: Adeshina O. Adekeye, et al.
Published: (2022-12-01) -
Past, present and future of the pathophysiological model of the basal ganglia
by: Jose A Obeso, et al.
Published: (2011-07-01) -
The Gene Expression of Proteins Involved in Intercellular Signaling and Neurodegeneration in the Substantia Nigra in a Mouse Subchronic Model of Parkinson’s Disease
by: Anna Kolacheva, et al.
Published: (2023-02-01) -
The Construction and Validation of a Novel Ferroptosis-Related Gene Signature in Parkinson’s Disease
by: Tingting Liu, et al.
Published: (2023-12-01)